Page last updated: 2024-08-23

paclitaxel and Blood Clot

paclitaxel has been researched along with Blood Clot in 238 studies

Research

Studies (238)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.42)	18.2507
2000's	104 (43.70)	29.6817
2010's	126 (52.94)	24.3611
2020's	7 (2.94)	2.80

Authors

Authors	Studies
Ceresnakova, M; Hudson, SP; Murray, D; Soulimane, T	1
Aihara, K; Ikari, Y; Kato, T; Nakamura, N; Nakazawa, G; Nakazawa, K; Noda, S; Torii, S	1
Intskirveli, N; Nakashidze, I; Patsia, L; Ratiani, L	1
Chen, H; Hong, J; Li, C; Lu, Q; Shi, B	1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z	1
Bottinor, W; Das, S; Nunnery, S	1
Fujihara, M; Iida, O; Katsuki, T; Kawasaki, D; Kozuki, A; Mano, T; Soga, Y; Takahara, M; Tsujimura, T	1
Battista, R; Coluccio, V; Grandi, G; Guidotti, I; Monari, F; Moscetti, L; Neri, I; Piombino, C; Torcetta, F; Toss, A	1
Cupic, VI; Stojanovic, M	1
Gao, RL; He, C; Jiang, L; Ma, YL; Tang, XF; Wang, CS; Xu, B; Yao, Y; Yuan, JQ; Zhang, JH	1
Bunch, F; Carr, J; Kassab, E; Walker, C	1
Bhurtu, A; Bundhun, PK; Huang, WQ; Pursun, M; Soogund, MZS; Teeluck, AR	1
Bae, ON; Bian, Y; Chang, YK; Chung, JH; Kim, K; Lim, KM	1
Cheng, RW; Chong, TT; Foo, WY; Gogna, A; Kho, YX; Pang, SC; Phang, CC; Tan, CS; Tan, CW; Tan, RY; Teh, SP	1
E, Y; Fan, H; He, N	1
Ahn, Y; Cho, HH; Hong, MH; Jeong, HY; Jeong, MH; Kang, WS; Kee, HJ; Kim, YS; Kwon, JS	1
Awata, M; Iida, O; Ishihara, T; Nanto, S; Shiraki, T; Uematsu, M	1
Akahori, H; Finn, AV; Habib, A; Karmali, V; Pachura, K; Polavarapu, R	1
García, E; Guarinos, J; Ioannidis, K; Larman, M; Moreu, J; Ortas, MR; Piqué, N; Puigfel, B; Rincón, A; Rumoroso, JR; Serra, A; Zueco, JJ	1
Bae, JH; Cho, JH; Cho, MC; Choi, YJ; Hur, SH; Hwang, JY; Jeong, MH; Jo, JH; Jung, KH; Jung, KT; Kang, TS; Kim, DI; Kim, KS; Kim, MH; Kim, TI; Kim, U; Kim, W; Kim, YJ; Lee, CH; Lee, HW; Lee, JH; Lee, SH; Lee, SW; Park, HS; Park, JS; Shin, DG; Son, JW	1
Inoue, K; Inoue, M; Kanaya, H; Matsubara, T; Miwa, K; Yasuda, T	1
Akhmedov, A; Beer, JH; Camici, GG; Eickner, T; Holy, EW; Jakob, P; Lüscher, TF; Schmitz, KP; Sternberg, K; Tanner, FC	1
De Luca, G; Di Lorenzo, E; Kaiser, C; Lee, JH; Suryapranata, H; Wirianta, J	1
Chechi, T; de la Llera, LS; De Luca, G; Di Lorenzo, E; Dirksen, MT; Kaiser, C; Kelbæk, H; Musto, C; Pasceri, V; Schalij, M; Spaulding, C; Spaziani, G; Stone, GW; Suryapranata, H; Thuesen, L; van der Hoeven, B; Vink, MA; Violini, R	1
Chen, F; Loh, JP; Omar, A; Pendyala, LK; Pichard, AD; Satler, LF; Torguson, R; Waksman, R	1
Chen, F; Lipinski, MJ; Pendyala, LK; Torguson, R; Waksman, R	1
Chechi, T; De Luca, G; Di Lorenzo, E; Dirksen, MT; Kaiser, C; Kelbæk, H; Spaziani, G; Stone, GW; Suryapranata, H; Thuesen, L; Vink, MA	1
Daida, H; Kasai, T; Konishi, H; Miyauchi, K; Naito, R; Ogita, M; Okazaki, S; Tamura, H; Tsuboi, S	1
Fischman, DL; Jasti, B; Kaliyadan, A; Ogilby, JD; Ruggiero, NJ; Savage, MP; Siu, H; Walinsky, P	1
Joner, M; Virmani, R; Yahagi, K	1
Guy, LG; Joner, M; Leclerc, G; Sanchez, OD; Virmani, R; Zarpak, R	1
Bossi, I; Bruschi, G; Colombo, P; De Marco, F; Klugmann, S; Oreglia, J; Piccalò, G; Soriano, F	1
Iida, O; Kawasaki, D; Nakano, M; Nanto, S; Soga, Y; Takahara, M; Uematsu, M; Yamauchi, Y; Yokoi, H; Zen, K	1
Joesoef, KS; McFadden, EP; Royaards, KJ; Smits, PC; van de Ent, M; van Mieghem, C; Vlachojannis, GJ; Wassing, J	1
Kang, X; Li, T; Sun, J	1
Dias, S; Petrou, P	1
Abe, H; Aizawa, T; Gotoh, R; Hozawa, H; Kadotani, M; Kashima, Y; Kawaguchi, R; Mibiki, Y; Nakagawa, Y; Nasu, K; Oikawa, Y; Okamura, A; Ota, H; Serikawa, T; Shirai, S; Suzuki, M; Suzuki, T; Takeda, Y; Tanabe, M; Tohara, S; Tsuji, T; Ujiie, Y; Usui, S; Yamashita, J	1
Dola, J; Kawecki, D; Marcinkiewicz, K; Morawiec, B; Nowalany-Kozielska, E; Ochała, A; Pluta, A; Smolka, G; Wańha, W; Wojakowski, W	1
Bundhun, PK; Chen, MH; Wu, ZJ	1
Apruzzese, PK; Camenzind, E; Cohen, DJ; Cutlip, DE; Gershlick, AH; Kereiakes, DJ; Massaro, JM; Mauri, L; Normand, SL; Rinaldi, MJ; Secemsky, EA; Song, Y; Spertus, JA; Steg, PG; Wijns, W; Yeh, RW	1
Klassen, KJ; Rizik, DG	1
Byrne, RA; Kastrati, A	1
Airaksinen, KE; Karjalainen, PP; Kervinen, K; Mäkikallio, T; Niemelä, M; Nyman, K; Pietili, M; Sia, J; Tuomainen, P; Ylitalo, A	1
Legrand, V; Nyssen, A; Scheen, AJ	1
Baboushkin, T; Eisenberg, MJ; Filion, KB; Rinfret, S; Roy, AM	1
Bøttcher, M; Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Krusell, LR; Lassen, JF; Maeng, M; Pedersen, L; Rasmussen, K; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH	1
Bonello, L; De Labriolle, A; Lemesle, G; Pakala, R; Scheinowitz, M; Waksman, R	1
Banning, A; Colombo, A; Dawkins, K; Grube, E; Guagliumi, G; Hauptman, K; Joshi, A; Marco, J; Mascioli, S; Thuesen, L; Wijns, W; Zmudka, K	1
Hartenthaler, B; Hofmann, R; Hönig, S; Kammler, J; Kerschner, K; Kypta, A; Lambert, T; Leisch, F; Steinwender, C	1
Darremont, O; de Marco, F; Garot, P; Lefèvre, T; Leymarie, JL; Louvard, Y; Morice, MC; Routledge, H; Silvestri, M; Unterseeh, T; Vaquerizo, B; Zwahlen, M	1
Baim, DS; Cannon, LA; Dobies, D; Hall, JJ; Lim, ST; Lucca, MJ; Mahmud, E; Mandinov, L; Mann, T; McClean, D; Ormiston, JA; Popma, JJ; Turco, MA; Weissman, N	1
Barlis, P; Regar, E; Schinkel, AF; Serruys, PW; van Beusekom, HM	1
Holmes, DR; Patel, M	1
Chevalier, B; Cutlip, DE; Di Mario, C; Fitzgerald, PJ; Grube, E; Neumann, FJ; Ormiston, J; Popma, JJ; Ribichini, F; Schwartz, LB; Urban, P; Whitbourn, R; Williams, DO	1
Cao, S; Cristea, E; Doostzadeh, J; Guiran, JB; Lansky, AJ; Midei, M; Mutlu, H; Newman, W; Ng, VG; Sanz, M; Sood, P; Stone, GW; Su, X; Sudhir, K; White, R	1
Bocksch, W; Boxberger, M; Degenhardt, R; Gross, M; Horstkotte, D; Nienaber, C; Schneider, H; Unverdorben, M; Vallbracht, C; Wiemer, M	2
Allocco, DJ; Baim, DS; Dawkins, KD; Leon, MB	1
Capasso, M; De Luca, G; Di Lorenzo, E; Lanzillo, T; Manganelli, F; Mariello, C; Pagliuca, MR; Rosato, G; Sauro, R; Siano, F; Stanco, G; Varricchio, A	1
Daemen, J; Garcia-Garcia, HM; Kukreja, N; Onuma, Y; Serruys, PW; van Domburg, R	1
Ladich, E; Nakazawa, G; Virmani, R	1
Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Martinez, EE; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE	1
Vlaar, PJ; Zijlstra, F	1
Berger, P; Cohen, DJ; Cutlip, D; Goldberg, S; Hong, M; Kellett, M; Kleiman, N; Mauri, L; Novack, V; Pencina, M; Raizner, AE; Waksman, R; Yen, CH	1
Airaksinen, KE; Karjalainen, PP; Kervinen, K; Mäkikallio, T; Niemelä, M; Nyman, K; Pietilä, M; Sia, J; Tuomainen, P; Ylitalo, A	1
Aharonian, VJ; Brar, SK; Brar, SS; Dangas, G; Gray, WA; Leon, MB; Moses, JW	1
Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; de Lemos, JA; Fasseas, P; Haagen, D; Holper, EM; Iturbe, JM; Kar, B; Karyofillis, P; Lichtenwalter, C; Obel, O; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Shunk, K; Voudris, VV	1
Endoh, A; Imai, K; Ishikawa, T; Kubota, T; Miyamoto, T; Mochizuki, S; Murakami, M; Mutoh, M; Nakano, Y; Nakata, K; Sakamoto, H; Suzuki, T; Yoshimura, M	1
Applegate, RJ; Cao, S; Doostzadeh, J; Gordon, PC; Hermiller, JB; Lansky, AJ; Stone, GW; Sudhir, K; Weinsier, SB	1
Erl, A; Hoppmann, P; Kastrati, A; Koch, W; Mehilli, J; Schömig, A; Tiroch, K; Türk, S	1
Choi, D; Fan, C; Hong, MK; Jang, Y; Kim, JS; Kim, TH; Kim, W; Ko, YG; Lee, JM	1
Chen, JP; Chronos, N; Geva, S; Goodchild, T; Hou, D; Jabara, R; Li, J; Pendyala, L; Robinson, K; Shinke, T; Ueno, T	1
Daemen, J; Garcia-Garcia, H; Kukreja, N; Onuma, Y; Serruys, PW; van Domburg, R	1
Baim, DS; Cox, DA; Dawkins, KD; Ellis, SG; Forman, DE; Joshi, AA; Lasala, JM; Ormiston, JA; Stone, GW; Turco, MA; Wei, JY	1
Carrie, D; Chevalier, B; Detiege, D; Garcia, E; Hauptmann, KE; Koolen, J; Morice, MC; Nagai, H; Park, SJ; Paunovic, D; Schuler, G; Serruys, PW; Silber, S; Suryapranata, H; van Es, GA; Wijns, W	1
Cook, S; Wenaweser, P	1
Bachinsky, WB; Baim, DS; Baran, K; Breall, JA; Cox, DA; Dawkins, KD; Dobies, D; Lasala, JM; Lewis, DH; Mascioli, SR; Rogers, EW; Song, A; Starzyk, RM	1
Beijk, MA; Claessen, BE; Henriques, JP; Legrand, V; Manari, A; Miquel-Hebert, K; Piek, JJ; Ruzyllo, W; Serruys, PW; Suttorp, MJ; Tijssen, JG; Varenne, O; Veldhof, S	1
Gruene, S; Huegl, B; Korn, HV; Lauer, B; Ohlow, MA; Petek, O; Schulte, W; Wagner, A; Wassmer, G; Yu, J	1
Buller, NP; Chue, CD; Doshi, SN; Epstein, AC; Ludman, PF; Routledge, HC; Townend, JN	1
Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F	1
Boland, J; Dorange, C; Garcia, E; Garg, S; Huber, K; Miquel-Hébert, K; Onuma, Y; Serruys, P; Sudhir, K; te Riele, JA; Veldhof, S	1
Baim, DS; Bergin, PJ; Bowman, TS; Caputo, R; Cox, DA; Ellis, SG; Hermiller, J; Mann, T; O'Shaughnessy, C; Stone, GW; Turco, M	1
Dawkins, KD; Doi, H; Ellis, SG; Grube, E; Maehara, A; Mandinov, L; Mintz, GS; Ormiston, JA; Popma, JJ; Stone, GW; Turco, MA; Wang, H; Weissman, NJ; Yu, A	1
Campos, C; Cano, M; Carballo, M; Costa, JR; Costa, RA; Maldonado, G; Moreira, AC; Pavanello, R; Sousa, A; Sousa, JE	1
Hermiller, J; Lansky, A; Miquel-Hebert, K; Onuma, Y; Serruys, PW; Seth, A; Sood, P; Stone, GW; Sudhir, K; Veldhof, S; Yu, S	1
Cassese, S; Chiariello, M; D'Andrea, C; De Rosa, R; Galasso, G; Piccolo, R; Piscione, F	1
Finn, AV; Virmani, R; Wilson, GJ	1
Battes, L; Boersma, E; de Boer, S; Magro, M; Onuma, Y; Serruys, PW; Simsek, C; van Domburg, RT	1
Hillegass, WB	3
Dawkins, KD	1
Goudevenos, JA; Kounis, NG	1
Bhatia, R; Ehdaie, A; Favaretto, E; Lee, MS; Tarantini, G; Tobis, J; Xhaxho, J; Yang, T	1
Allocco, DJ; Curzen, N; Dawkins, KD; Grube, E; Hauptmann, KE; Nickenig, G; Schofer, J	1
Cassese, S; Chiariello, M; Esposito, G; Gargiulo, G; Piscione, F; Sannino, A; Schiattarella, GG	1
Cao, S; Caputo, R; Cutlip, DE; Doostzadeh, J; Kereiakes, DJ; Lansky, AJ; Mastali, K; Newman, W; Rizvi, A; Simonton, CA; Stone, GW; Sudhir, K; Wang, JC	1
Hillis, LD; Lange, RA	1
Girasis, C; Kukreja, N; Onuma, Y; Serruys, P; van Domburg, R; Wong, CK	1
Dawkins, KD; Ellis, SG; Grube, E; Mandinov, L; Mintz, GS; Ormiston, J; Steinberg, DH; Stone, GW; Turco, MA; Weissman, NJ; Yu, A	1
Lindsey, JB; Marso, SP	1
Bhambhani, A; Billinger, M; Cook, S; Hellige, G; Hofmann, A; Jüni, P; Meier, B; Millauer, N; Räber, L; Seiler, C; Togni, M; Urwyler, N; Vogel, R; Wandel, S; Wenaweser, P; Windecker, S	1
Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Lassen, JF; Madsen, M; Maeng, M; Ravkilde, J; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH	1
Antoniucci, D; Barbagallo, R; Cera, M; Chieffo, A; Colombo, A; Di Mario, C; Furuichi, S; Godino, C; Goktekin, O; Grube, E; Latib, A; Mueller, R; Parodi, G; Reimers, B; Sangiorgi, GM; Tamburino, C	1
Agostoni, P; Banerjee, S; Brilakis, ES; Kandzari, DE; Lombardi, WL; Rangan, BV; Saeed, B	1
Cho, YK; Hong, GR; Hur, SH; Kim, DI; Kim, DK; Kim, DS; Kim, HS; Kim, KB; Kim, U; Kim, YJ; Lee, SH; Nam, CW; Park, JS; Seol, SH; Shin, DG; Yang, TH	1
Akin, I; Bufe, A; Eckardt, L; Kuck, KH; Nienaber, CA; Reinecke, H; Richardt, G; Schneider, S; Senges, J	1
Chen, LL; Lin, CG; Lin, QF; Luo, YK; Peng, YF; Zhen, XC	1
Chen, JP; Chen, SL; Jiang, Q; Kan, J; Mintz, G; Stone, GW; Sun, X; Xu, B; Xu, Y; Ye, F; Zhang, A; Zhang, J	1
Berger, PB; Bowman, TS; Brilakis, ES; Cox, DA; Dawkins, KD; Lasala, JM; Starzyk, RM	1
Aparci, M; Cebeci, BS; Kardesoglu, E; Ozmen, N; Yiginer, O	1
Abelson, M; Brown, B; Conway, D; Hellig, F; Hirata, K; Khan, S; Kozuki, A; Miyoshi, N; Mpe, M; Ntsekhe, M; Sawada, T; Shinke, T; Shite, J	1
Brodie, B; Dressler, O; Guagliumi, G; Guo, N; He, Y; Kellett, MA; Lansky, AJ; Maehara, A; Mehran, R; Mintz, GS; Parise, H; Stone, GW; Witzenbichler, B; Wu, X; Xu, K	1
Bae, JH; Cha, KS; Chae, SC; Gwon, HC; Hong, SJ; Hur, SH; Kim, MH; Lim, DS; Park, HS	1
Birkmeier, KA; Byrne, RA; Holle, H; Kastrati, A; Kufner, S; Laugwitz, KL; Massberg, S; Mehilli, J; Schömig, A; Schulz, S; Tiroch, K	1
Antoniucci, D; Bernardi, V; Bettinoti, M; Curotto, V; Delacasa, A; Fernandez-Pereira, C; Mieres, J; Palacios, IF; Rodriguez, AE; Rodriguez-Granillo, AM; Rodriguez-Granillo, G; Rubilar, B; Santaera, O; Tronge, J; Vigo, CF	1
Ahmed, WH; Mendiz, OA; Thomas, MR	1
Cutlip, DE; Kandzari, DE; Leon, MB; Liberman, H; Mauri, L; Moses, J; Nikolsky, E; Patterson, J; Wilson, H	1
Boersma, E; Gaspersz, MP; Magro, M; Nauta, ST; Onuma, Y; Serruys, PW; Simsek, C; van der Giessen, WJ; van Domburg, RT	1
Akasaka, T; Hirata, K; Ikejima, H; Imanishi, T; Ino, Y; Ishibashi, K; Kashiwagi, M; Kitabata, H; Komukai, K; Kubo, T; Liu, Y; Mizukoshi, M; Ozaki, Y; Tanaka, A; Tanimoto, T; Tsujioka, H	1
Giannopoulos, S; Goudevenos, JA; Kounis, NG	1
Haraguchi, Y; Hariki, H; Hirata, K; Honjo, T; Inoue, T; Ishida, T; Kawamori, H; Kozuki, A; Nishio, R; Sawada, T; Shinke, T; Shinohara, M; Shite, J; Toh, R	1
Sakata, Y	1
Park, SJ	1
Hayashi, Y; Hirao, H; Kawase, T; Masaoka, Y; Mito, S; Motoda, C; Muraoka, Y; Okimoto, T; Otsuka, M; Takeda, R; Tamekiyo, H; Toyofuku, M; Ueda, H; Watanabe, N	1
Altay, H; Binici, S; Ciçek, D; Haberal, C; Kalay, N; Müderrisoğlu, H; Pekdemir, H	1
Charnigo, R; Moliterno, DJ; Ziada, KM	1
Dirksen, MT; Kiemeneij, F; Laarman, GJ; Patterson, MS; Slagboom, T; Suttorp, MJ; Tijssen, JG; van Etten, J; Vink, MA	1
Bensimhon, A; Brodie, B; Cooper, M; Fleishman, N; Hansen, C; Kissling, G; McAlhany, C; Milks, S; Pokharel, Y; Stuckey, T	1
Bhindi, R; Khachigian, LM; Li, Y	1
Abdel-karim, AR; Addo, T; Banerjee, S; Berger, P; Bissett, JK; Brilakis, ES; de Lemos, JA; Fasseas, P; Haagen, D; Kar, B; Karyofillis, P; Lichtenwalter, C; Obel, O; Rangan, BV; Roesle, M; Rossen, J; Sachdeva, R; Saeed, B; Voudris, VV	1
Butman, SM	2
Morino, Y	1
Chae, JK; Cho, YH; Choi, SW; Chun, KJ; Jeong, JO; Kang, SJ; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Rhee, KS; Seong, IW; Yun, SC	1
Ben-Dor, I; Delhaye, C; Gaglia, MA; Gonzalez, MA; Kent, KM; Mahmoudi, M; Maluenda, G; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Wakabayashi, K; Waksman, R; Xue, Z	1
Dänschel, W; Desch, S; Erbs, S; Gielen, S; Kleinertz, K; Lauer, B; Linke, A; Möbius-Winkler, S; Schloma, D; Schuler, G; Thiele, H; Yu, J	1
Joesoef, KS; Kedhi, E; McFadden, E; Rademaker-Havinga, TA; Royaards, KJ; Smits, PC; Wassing, J	1
Applegate, RJ; Cannon, LA; Cutlip, DE; Kereiakes, DJ; Maddux, JT; Newman, W; Rizvi, A; Simonton, CA; Sood, P; Stone, GW; Sudhir, K	1
Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Hong, KP; Lee, SH; Park, JE; Ryu, DR; Song, PS; Song, YB	1
Baan, J; Beijk, MA; de Winter, RJ; Henriques, JP; Klomp, M; Koch, KT; Piek, JJ; Tijssen, JG; van Geloven, N; Vis, MM	1
Bleuit, JS; Colombo, A; Dawkins, KD; Ellis, SG; Grube, E; Popma, JJ; Russell, ME; Stone, GW; Uchida, T	1
Fujii, K; Gabbiani, G; Hao, H; Hirota, S; Ishibashi-Ueda, H; Shite, J; Tsujimoto, M; Ueda, Y	1
Ahn, Y; Cho, AS; Hong, MH; Jeong, MH; Jeong, SY; Kim, JS; Kim, YS; Kwon, JS	1
Asai, M; Higo, T; Hirata, A; Kashiwase, K; Kodama, K; Matsuo, K; Murakami, A; Nemoto, T; Nishio, M; Ueda, Y	1
Bowman, TS; Cox, DA; Dawkins, KD; Lasala, JM; Lee, MS; Starzyk, RM; Yang, T	1
Bates, ER; Menees, DS	1
Agnifili, M; Bedogni, F; Brambilla, N; Lanotte, S; Latini, RA; Laudisa, ML; Pizzocri, S; Testa, L	1
Ahn, TH; Han, SH; Kang, WC; Lee, KH; Moon, J; Shin, EK; Suh, SY	1
Baldinger, SH; Hess, N; Hess, OM; Jüni, P; Laube, E; Lauterburg, A; Limacher, A; Lötscher, S; Meier, B; Moschovitis, A; Räber, L; Wenaweser, P	1
Agostoni, P; Belkacemi, A; Sangiorgi, G; Silber, S; Stahnke, S; Stella, PR; Torguson, R; von Strandmann, RP; Waksman, R	1
Bonaventura, K; Boxberger, M; Kleber, FX; Mathey, DG; Wendig, I	1
Claessen, BE; Cristea, E; Fahy, M; Kedhi, E; Kereiakes, DJ; Lansky, AJ; Parise, H; Serruys, PW; Simonton, CA; Smits, PC; Sood, P; Stone, GW; Sudhir, K	1
Bege, N; Curdy, C; Janek, J; Kalinowski, M; Kissel, T; Klaus, S; Petersen, H; Reul, R; Steinmüller, SO	1
Böhm, M; Clever, Y; Cremers, B; Scheller, B	1
Chen, YQ; Ling, ZY; Liu, G; She, Q; Su, L; Yin, YH; Yuan, J; Zhang, L; Zhong, JP	1
Aghajani, H; Alidoosti, M; Amirzadegan, AR; Hajizeinali, AM; Hakki-Kazazi, E; Kassaian, SE; Nematipour, E; Poorhosseini, H; Salarifar, M; Shafiee, N; Sheikhfathollahi, M; Tokaldany, ML	1
Abdel-Wahab, M; Baev, R; Dieker, P; Geist, V; Kassner, G; Khattab, AA; Richardt, G; Sulimov, D; Toelg, R	1
Borghesi, M; Campo, G; Cangiano, E; Castriota, F; Cavazza, C; Colombo, F; Ferrari, R; Frangione, A; Fucà, G; Kubbajeh, M; Marchesini, J; Minarelli, M; Monti, M; Parrinello, G; Percoco, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P	1
Biondi-Zoccai, G; Briguori, C; D'Ascenzo, F; De Waha, A; Della Riva, D; Kaiser, C; Kedhi, E; Kim, HS; Kimura, T; Kirtane, AJ; Leon, MB; Marullo, A; Palmerini, T; Sabatè, M; Sangiorgi, D; Sardella, G; Smits, PC; Stettler, C; Stone, GW	1
Renzulli, A; Rossi, M; Serraino, GF; Spadafora, A	1
Barbash, IM; Hauville, C; Laynez, A; Pakala, R; Pichard, AD; Sardi, G; Satler, LF; Torguson, R; Waksman, R; Xue, Z	1
Chechi, T; Cortese, G; De Luca, G; Di Lorenzo, E; Díaz de la Llera, LS; Dirksen, MT; Kaiser, C; Kelbaek, H; Musto, C; Pasceri, V; Schalij, M; Spaulding, C; Spaziani, G; Stone, GW; Suryapranata, H; Thuesen, L; van der Hoeven, B; Vink, MA; Violini, R	1
Applegate, RJ; Cao, S; Ferguson, JM; Gordon, PC; Hermiller, JB; Rizvi, A; Smith, RS; Sood, P; Stone, GW; Sudhir, K; Wang, J; Yaqub, M	1
Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE	1
Bachmann, S; Dütting, S; Hagedorn, I; Italiano, JE; Kunert, S; Meyer, I; Nieswandt, B; Schulze, H; Schwiebert, S	1
Batchelor, WB; Ellis, SG; Joshi, AA; Ormiston, JA; Stone, GW; Underwood, PL; Wang, H	1
Mazurova, VV; Sukhorukov, OE; Zakharova, OV	1
Boatta, E; Cannavale, A; Cirelli, C; Corona, M; Fanelli, F; Lucatelli, P; Salvatori, FM; Wlderk, A	1
Arora, R; Bahekar, A; Bajaj, A; Bhuriya, R; Khosla, S; Sethi, A; Singh, PP	1
Ahn, JM; Kang, SJ; Kim, WJ; Kim, YH; Lee, BK; Lee, CW; Lee, JH; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Seong, IW; Song, HG; Yun, SC	1
Hariki, H; Hiranuma, N; Hirata, K; Inoue, T; Kawamori, H; Kozuki, A; Matsumoto, D; Nagoshi, R; Nakagawa, M; Nishio, R; Osue, T; Otake, H; Shinke, T; Shite, J; Taniguchi, Y	1
Boura, J; Harjai, KJ; Harjai, N; Kondareddy, S; Orshaw, P; Pinkosky, B	1
Auer, J; Berent, R; Eber, B; Weber, T	1
Dawson, KA; Gallagher, WM; Kavanagh, CA; Keenan, AK; Rochev, YA	1
Ajani, AE; Waksman, R	1
Chan, C; Wong, A	1
Farb, A; Guagliumi, G; Kolodgie, FD; Virmani, R	1
Gross, TP; Muni, NI	1
Yamaguchi, T	2
Edelman, ER; Hwang, CW; Jonas, M; Levin, AD; Li, PH	1
Airoldi, F; Bonizzoni, E; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Corvaja, N; Ge, L; Gerckens, U; Grube, E; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, GM; Schmidt, T; Stankovic, G	1
Crepin, F; Decoene, C; Fabre, O; Pol, A; Vincentelli, A	1
Boccuzzi, G; Pagnotta, P; Presbitero, P	1
Alvarez, W	1
Berrocal, D; Fernandez-Pereira, C; Grinfeld, L; Mieres, J; Palacios, I; Rodriguez, AE; Rodriguez-Alemparte, M; Vigo, CF	1
Kaneda, H	1
Albaladejo, P; Collet, JP; Marret, E; Montalescot, G	1
Bee, H; Lee, CH; Lim, YT; Low, A; Soon, CY; Tan, HC; Teo, SG; Zhang, JJ	1
Bui, A; Chu, WW; Clavijo, LC; Fournadjieva, J; Gevorkian, N; Kent, KM; Kim, SW; Kuchulakanti, PK; Ohlmann, P; Pichard, AD; Rha, SW; Satler, LF; Smith, K; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Hida, K; Ikeda, S; Ohta, H; Orito, S; Shimizu, S; Tatsuduki, A; Yoshikata, R	1
Diamond, GA; Kaul, S; Shah, PK; Tung, R	1
Akhmedov, A; Camici, GG; Graber, M; Lüscher, TF; Shojaati, K; Stähli, BE; Steffel, J; Tanner, FC	1
Bates, ER; Nallamothu, BK; Tsai, TT	1
Dirksen, MT; Kiemeneij, F; Laarman, GJ; Patterson, M; Rensing, BJ; Slagboom, T; Suttorp, MJ; Tijssen, JG; van der Wieken, LR; van Heerebeek, L	1
Abbott, JD; Kip, KE; Williams, DO	1
Kukreja, N; Serruys, PW	1
Kandzari, DE	1
D'Souza, S; Dalal, AR; Shulman, MS	1
Bavry, AA; Bhatt, DL; Borek, PP; Helton, TJ; Kumbhani, DJ; Mood, GR	1
Caves, JM; Chaikof, EL	1
Jneid, H; Maree, AO; Palacios, IF	1
Albaladejo, P; Lehot, JJ; Marcotte, G; Marret, E; Monier, F; Piriou, V; Samama, CM; Vichova, Z	1
Kereiakes, DJ	1
Buchbinder, M; Colombo, A; Galassi, AR; Grasso, C; Tamburino, C; Tomasello, SD; Ussia, GP	1
Htay, T; Liu, MW	1
Colombo, A; Dawkins, KD; Ellis, SG; Grube, E; Koglin, J; Popma, J; Stone, GW	1
Kløw, NE	1
Kedia, G; Lee, MS	1
Burelli, C; Cassin, M; De Biasio, M; Driussi, M; Macor, F; Nicolosi, GL; Vendrametto, F	1
Di Sciascio, G; Pasceri, V; Patti, G; Pristipino, C; Richichi, G; Speciale, G	1
Hansen, PR	1
Caldera, AE; Cohen, DJ; Granada, JF; Kleiman, NS; Lopez, J; Maresh, K; Marulkar, S; Nassif, D; Parikh, MA; Rihal, CS; Win, HK	1
Gevorkian, N; Kent, KM; Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LL; Smith, K; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Gori, AM; Marcucci, R; Migliorini, A; Moschi, G; Paniccia, R; Santini, A	1
Yamamoto, H	1
Benoît, A; Berger, A; Goy, JJ; Seydoux, C; Siegenthaler, M; Stauffer, JC	1
Airoldi, F; Bonizzoni, E; Briguori, C; Buellesfeld, L; Carlino, M; Chieffo, A; Colombo, A; Cosgrave, J; Gerckens, U; Godino, C; Grube, E; Latib, A; Melzi, G; Michev, I; Montorfano, M; Morici, N; Qasim, A; Sangiorgi, GM	1
Bavry, AA; Bhatt, DL	1
Huibregtse, BA; Poff, BC; Polovick, JE; Wilson, GJ	1
Bystron, M; Cervinka, P; Jakabcin, J; Kala, P; Kvasnak, M; Malý, J; Spacek, R; Veselka, J	1
Chen, YD; Jin, ZN; Lu, SZ; Zhao, FH	1
Ormiston, JA; Webster, MW	1
de Korte, FI; Ten Berg, JM; van Werkum, JW; Vijverberg, PL	1
Collins, MB; Dangas, G; Fahy, M; Gray, WA; Kim, YH; Kirtane, AJ; Kodali, SK; Lansky, AJ; Leon, MB; Mehran, R; Moses, JW; Moussa, I; Pucelikova, T; Stone, GW; Weisz, G	1
Celebi, O; Eisenreich, A; Goldin-Lang, P; Rauch, U; Schultheiss, HP	1
Aarøe, J; Abildgaard, U; Abildstrøm, SZ; Andersen, HR; Bligaard, N; Bøtker, HE; Engstrøm, T; Galatius, S; Galløe, AM; Hansen, PR; Jensen, JS; Junker, A; Kelbaek, H; Kristensen, SD; Krusell, LR; Lassen, JF; Madsen, JK; Rasmussen, K; Ravkilde, J; Saunamäki, K; Stephansen, GB; Thayssen, P; Thuesen, L	1
Moliterno, DJ; Mukherjee, D	1
Batyraliev, TA; Pershukov, IV	1
Colombo, A	1
Chen, J; Chen, JL; Dai, J; Gao, RL; Huang, JH; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ	1
Bonaros, N; Bonatti, J; Heiss, S; Laufer, G; Mayr, T; Reisinger, P; Schachner, T; Steger, C; Zipponi, D	1
Kurz, C; Mayerhofer, K; Obermair, A; Sevelda, P; Stolzlechner, J	1
Farb, A; Kolodgie, FD; Virmani, R	1
Bourantas, CV; Colombo, A; Dawkins, KD; de Vries, T; Farooq, V; Feldman, T; Holmes, DR; Kappetein, AP; Mack, M; Mohr, FW; Morel, MA; Morice, MC; Serruys, PW; Ståhle, E; Zhang, Y	1

Reviews

43 review(s) available for paclitaxel and Blood Clot

Article	Year
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Long-term (2-5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis. Scientific reports, 2017, 07-25, Volume: 7, Issue:1 Topics: Antineoplastic Agents; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome	2017
Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Journal of thrombosis and thrombolysis, 2014, Volume: 38, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; MEDLINE; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Time Factors	2014
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation. Clinical research in cardiology : official journal of the German Cardiac Society, 2014, Volume: 103, Issue:9 Topics: Aged; Angioplasty; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome	2014
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. Journal of thrombosis and thrombolysis, 2015, Volume: 39, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Thrombosis; Time Factors	2015
A novel "pro-healing" approach: the COMBO™ dual therapy stent from a pathological view. Minerva cardioangiologica, 2015, Volume: 63, Issue:1 Topics: Antibodies, Monoclonal; Antigens, CD34; Drug-Eluting Stents; Endothelial Progenitor Cells; Humans; Neointima; Paclitaxel; Polymers; Prosthesis Design; Sirolimus; Thrombosis	2015
[A simple but very complicated angioplasty: management of coronary artery perforation and dual antiplatelet therapy. A case report and literature review]. Giornale italiano di cardiologia (2006), 2015, Volume: 16, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Cardiac Tamponade; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Everolimus; Heparin; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Reoperation; Sirolimus; Thrombosis; Treatment Outcome	2015
A mixed treatment comparison for short- and long-term outcomes of bare-metal and drug-eluting coronary stents. International journal of cardiology, 2016, Jan-01, Volume: 202 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Death; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Sirolimus; Stents; Thrombosis; Treatment Outcome	2016
Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine, 2016, Volume: 95, Issue:5 Topics: Aged; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Odds Ratio; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome	2016
Assessing the landscape of stent thrombosis: the drug-eluting versus bare-metal stent controversy. The American journal of cardiology, 2008, Nov-03, Volume: 102, Issue:9 Suppl Topics: Drug-Eluting Stents; Humans; Metals; Paclitaxel; Randomized Controlled Trials as Topic; Stents; Thrombosis; Time Factors	2008
Paclitaxel-eluting balloon: from bench to bed. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Apr-01, Volume: 73, Issue:5 Topics: Angioplasty, Balloon, Coronary; Animals; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Design; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Thrombosis; Treatment Outcome	2009
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:4 Topics: Coronary Angiography; Death; Drug-Eluting Stents; Equipment Design; Humans; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Patient Selection; Randomized Controlled Trials as Topic; Recurrence; Risk; Sirolimus; Thrombosis; Treatment Outcome	2009
A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:7 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Least-Squares Analysis; Metals; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Feb-15, Volume: 77, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Occlusion; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Mar-01, Volume: 77, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Recent developments in drug-eluting stents. Journal of molecular medicine (Berlin, Germany), 2011, Volume: 89, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Paclitaxel; Polymers; Sirolimus; Thrombosis; Treatment Outcome	2011
[Types and characteristic features of drug-eluting stents]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:2 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents; Drug-Eluting Stents; Everolimus; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis	2011
Drug-eluting stent: importance of clinico-pathological correlations. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:7 Topics: Coronary Vessels; Drug-Eluting Stents; Humans; Hyperplasia; Inflammation; Neointima; Paclitaxel; Risk Factors; Sirolimus; Thrombosis	2011
Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis. QJM : monthly journal of the Association of Physicians, 2011, Volume: 104, Issue:12 Topics: Chromium Alloys; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Randomized Controlled Trials as Topic; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Treatment Outcome; Tubulin Modulators	2011
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet (London, England), 2012, Apr-14, Volume: 379, Issue:9824 Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Evidence-Based Medicine; Female; Humans; Incidence; Italy; Male; Paclitaxel; Prognosis; Prosthesis Failure; Radiography; Randomized Controlled Trials as Topic; Risk Assessment; Sirolimus; Stents; Survival Analysis; Thrombosis	2012
What do you do with the antiplatelet agents in patients with drug eluting stents who then receive a mechanical valve? Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:1 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Aspirin; Benchmarking; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Evidence-Based Medicine; Female; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome	2012
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Archives of internal medicine, 2012, Apr-23, Volume: 172, Issue:8 Topics: Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Heart Conduction System; Humans; Incidence; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Paclitaxel; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2012
Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trials. Archives of cardiovascular diseases, 2012, Volume: 105, Issue:11 Topics: Coated Materials, Biocompatible; Confidence Intervals; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Equipment Failure; Follow-Up Studies; Humans; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Phosphorylcholine; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Treatment Outcome	2012
Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacology & therapeutics, 2004, Volume: 102, Issue:1 Topics: Acrylamides; Angioplasty, Balloon; Coronary Restenosis; Drug Delivery Systems; Humans; Hydrogels; Immunosuppressive Agents; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Sirolimus; Stents; Thrombosis	2004
Drug-eluting stents: the end of restenosis? Annals of the Academy of Medicine, Singapore, 2004, Volume: 33, Issue:4 Topics: Coronary Restenosis; Humans; Hyperplasia; Metals; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; Tunica Intima	2004
Drug-eluting stents: caution and concerns for long-term outcome. Coronary artery disease, 2004, Volume: 15, Issue:6 Topics: Animals; Coronary Restenosis; Device Approval; Humans; Hypersensitivity; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis; United States; Wound Healing	2004
[New generation of percutaneous coronary intervention: drug-eluting stent]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2 Topics: Angioplasty; Antineoplastic Agents; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis	2005
[Recent progress and problems in percutaneous coronary intervention]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-20, Volume: 94 Suppl Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis; Warfarin	2005
Drug eluting stents in acute myocardial infarction. Panminerva medica, 2005, Volume: 47, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Humans; Immunosuppressive Agents; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis	2005
Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence. Annals of internal medicine, 2006, Jun-20, Volume: 144, Issue:12 Topics: Angioplasty, Balloon, Coronary; Coronary Restenosis; Cost-Benefit Analysis; Drug Delivery Systems; Equipment Design; Humans; Paclitaxel; Radiography; Randomized Controlled Trials as Topic; Sirolimus; Stents; Thrombosis	2006
Brief review: coronary drug-eluting stents and anesthesia. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2006, Volume: 53, Issue:12 Topics: Anesthesia; Coronary Vessels; Drug-Eluting Stents; Hemorrhage; Humans; Intraoperative Complications; Paclitaxel; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Sirolimus; Thrombosis	2006
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. The American journal of medicine, 2006, Volume: 119, Issue:12 Topics: Coronary Disease; Drug Delivery Systems; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2006
The evolving impact of microfabrication and nanotechnology on stent design. Journal of vascular surgery, 2006, Volume: 44, Issue:6 Topics: Angioplasty; Graft Occlusion, Vascular; Humans; Nanotechnology; Paclitaxel; Peripheral Vascular Diseases; Prosthesis Design; Sirolimus; Stents; Thrombosis	2006
Drug-eluting stent: a review and update. Vascular health and risk management, 2005, Volume: 1, Issue:4 Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Carriers; Growth Inhibitors; Humans; Hyperplasia; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; Treatment Outcome; Tunica Intima	2005
Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. Journal of the American College of Cardiology, 2007, Mar-13, Volume: 49, Issue:10 Topics: Adolescent; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Cardiac Catheterization; Confidence Intervals; Coronary Angiography; Coronary Stenosis; Drug Administration Routes; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Probability; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Risk Assessment; Stents; Survival Analysis; Taxus; Thrombosis; Time Factors	2007
Stent thrombosis with drug-eluting stents: a re-examination of the evidence. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, May-01, Volume: 69, Issue:6 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clinical Trials as Topic; Drug Administration Schedule; Humans; Incidence; Metals; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Research Design; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2007
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction. American heart journal, 2007, Volume: 153, Issue:5 Topics: Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Risk; Sirolimus; Stents; Survival Analysis; Thrombosis; Treatment Outcome; Tubulin Modulators	2007
[Late stent thrombosis with drug eluting stents: disturbing signals on the radar]. Ugeskrift for laeger, 2007, Apr-23, Volume: 169, Issue:17 Topics: Coronary Restenosis; Drug Delivery Systems; Humans; Paclitaxel; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2007
[Present circumstance around percutaneous coronary intervention (PCI): before and after drug eluting stent (DES) introduction]. Nihon Hoshasen Gijutsu Gakkai zasshi, 2007, Jun-20, Volume: 63, Issue:6 Topics: Angioplasty, Balloon, Coronary; Atherectomy; Coronary Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Thrombosis	2007
[Drug-eluting stent thrombosis and its pharmacological prevention]. Kardiologiia, 2007, Volume: 47, Issue:7 Topics: Aspirin; Clopidogrel; Death, Sudden, Cardiac; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Incidence; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Terminology as Topic; Thrombosis; Ticlopidine; Turkey	2007
Histopathologic alterations after endovascular radiation and antiproliferative stents: similarities and differences. Herz, 2002, Volume: 27, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Brachytherapy; Coronary Restenosis; Coronary Vessels; Fibrin; Follow-Up Studies; Humans; Iliac Artery; Inflammation; Microscopy, Electron, Scanning; Paclitaxel; Platelet Aggregation; Rabbits; Radiation-Sensitizing Agents; Stainless Steel; Stents; Swine; Thrombosis	2002

Trials

56 trial(s) available for paclitaxel and Blood Clot

Article	Year
The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1 Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus	2016
Effect and significance of hyperlipoproteinemia on stent thrombosis in patients with implanted drug-eluting stents: The 5-year follow up study. The American journal of the medical sciences, 2022, Volume: 364, Issue:6 Topics: Adult; Drug-Eluting Stents; Follow-Up Studies; Humans; Hyperlipoproteinemias; Paclitaxel; Retrospective Studies; Thrombosis; Treatment Outcome	2022
Long-term clinical performance of paclitaxel-eluting stents coated with a bioactive polymer (P-5) containing a triflusal derivative: results of the REWAC registry. The Journal of invasive cardiology, 2013, Volume: 25, Issue:8 Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Registries; Salicylates; Thrombosis; Treatment Outcome	2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE study. Journal of Korean medical science, 2013, Volume: 28, Issue:11 Topics: Antineoplastic Agents, Phytogenic; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Sirolimus; Thrombosis; Treatment Outcome	2013
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revasculariza JACC. Cardiovascular interventions, 2015, Aug-17, Volume: 8, Issue:9 Topics: Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Single-Blind Method; Thrombosis; Time Factors; Treatment Outcome	2015
Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA, 2016, Apr-26, Volume: 315, Issue:16 Topics: Age Factors; Aged; Antineoplastic Agents, Phytogenic; Aspirin; Diabetes Mellitus; Drug-Eluting Stents; Female; Hemorrhage; Humans; Ischemia; Linear Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyridines; Risk Assessment; Risk Factors; Smoking; Thrombosis; Time Factors	2016
Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2008, Volume: 4, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Recurrence; Risk Factors; Thrombosis; Titanium; Treatment Outcome	2008
TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coated Materials, Biocompatible; Coronary Artery Disease; Double-Blind Method; Drug-Eluting Stents; Europe; Humans; Kaplan-Meier Estimate; Metals; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry. Circulation, 2009, May-05, Volume: 119, Issue:17 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries; Survival Analysis; Thrombosis; Treatment Outcome	2009
Direct stenting with the TAXUS Liberté drug-eluting stent: results from the Taxus Atlas Direct Stent Study. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Male; Middle Aged; New Zealand; Paclitaxel; Prospective Studies; Prosthesis Design; Severity of Illness Index; Singapore; Thrombosis; Time Factors; Treatment Outcome; United States	2008
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Australia; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Logistic Models; Male; Middle Aged; New Zealand; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2008
Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Nov-01, Volume: 74, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Linear Models; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Sex Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Women's Health	2009
The paclitaxel-eluting Coroflex Please stent study (PECOPS I): the 3-year clinical follow-up. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Nov-01, Volume: 74, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome	2009
Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:6 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Disease Progression; Double-Blind Method; Drug-Eluting Stents; Humans; Metals; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Recurrence; Risk Assessment; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2009, Nov-01, Volume: 74, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Cardiovascular Diseases; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Hyperplasia; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Annals of medicine, 2009, Volume: 41, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Stents; Thrombosis; Time Factors; Titanium; Treatment Outcome; Tubulin Modulators	2009
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:9 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Graft Occlusion, Vascular; Greece; Humans; Metals; Myocardial Infarction; Paclitaxel; Prosthesis Design; Recurrence; Saphenous Vein; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome; United States	2009
Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Feb-01, Volume: 75, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Prospective Studies; Registries; Risk Assessment; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States	2010
Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Angioplasty, Balloon, Coronary; Asia; Australia; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Europe; Female; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk Assessment; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2009
Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; United States	2009
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; New Zealand; Paclitaxel; Prospective Studies; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2009
Interventional therapy of bifurcation lesions: a TIMI flow-guided concept to treat side branches in bifurcation lesions--a prospective randomized clinical study (Thueringer bifurcation study, THUEBIS study as pilot trial). Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Prospective Studies; Single-Blind Method; Thrombosis; Time Factors; Treatment Outcome	2009
Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e Journal of cardiovascular medicine (Hagerstown, Md.), 2010, Volume: 11, Issue:7 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Biomarkers; Cardiac Catheterization; Cardiovascular Agents; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Endothelium, Vascular; Humans; Italy; Longitudinal Studies; Paclitaxel; Prosthesis Design; Research Design; Single-Blind Method; Thrombosis; Time Factors; Tomography, Optical Coherence; Trapidil; Treatment Outcome; Vascular Endothelial Growth Factor A	2010
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Europe; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States	2009
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:4 Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; England; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2010
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. The New England journal of medicine, 2010, May-06, Volume: 362, Issue:18 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Glycoprotein GPIIb-IIIa Complex; Retreatment; Single-Blind Method; Sirolimus; Thrombosis; Treatment Failure	2010
Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2010
Choice of stenting strategy in true coronary artery bifurcation lesions. Coronary artery disease, 2010, Volume: 21, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
STELLIUM 1: First-in-man follow-up evaluation of bioabsorbable polymer-coated paclitaxel-eluting stent. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:10 Topics: Aged; Angina Pectoris; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Inflammation; Male; Middle Aged; Neointima; Paclitaxel; Polymers; Postoperative Complications; Thrombosis; Treatment Outcome	2010
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization a Circulation, 2010, Sep-14, Volume: 122, Issue:11 Topics: Aged; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Prospective Studies; Risk Factors; Stents; Thrombosis; Treatment Outcome; Ultrasonography, Interventional	2010
Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in diabetic patients: prospective randomized multicenter trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Dec-01, Volume: 76, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Feb-15, Volume: 77, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Argentina; Cardiovascular Agents; Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Glycocalyx; Humans; Kaplan-Meier Estimate; Lactic Acid; Logistic Models; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States	2010
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Metals; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Bypass; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Saphenous Vein; Single-Blind Method; Stents; Thrombosis; Time Factors; Treatment Outcome; United States	2011
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2011
Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent i Journal of the American College of Cardiology, 2011, Jun-28, Volume: 58, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Paclitaxel; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Tubulin Modulators	2011
Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. Journal of the American College of Cardiology, 2011, Jun-28, Volume: 58, Issue:1 Topics: Adolescent; Adult; Aged; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Thrombosis; Treatment Outcome; Tubulin Modulators	2011
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Aug-01, Volume: 78, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Endothelial Cells; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Stem Cells; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Europe; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome; United States	2011
Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7 Suppl K Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Catheters; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug Delivery Systems; Equipment Design; Female; Germany; Humans; Male; Metals; Middle Aged; Paclitaxel; Pilot Projects; Prospective Studies; Prosthesis Design; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease. Journal of interventional cardiology, 2012, Volume: 25, Issue:6 Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Patient Readmission; Polymers; Sirolimus; Thrombosis	2012
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation, 2012, Apr-24, Volume: 125, Issue:16 Topics: Aged; Aged, 80 and over; Aspirin; Cause of Death; Clopidogrel; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk; Sirolimus; Stroke; Thrombosis; Ticlopidine; Treatment Outcome	2012
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, May-15, Volume: 8, Issue:1 Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; Single-Blind Method; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, May-15, Volume: 8, Issue:1 Topics: Absorbable Implants; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2012, Volume: 19, Issue:5 Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angioplasty, Balloon; Arterial Occlusive Diseases; Cardiovascular Agents; Constriction, Pathologic; Drug Carriers; Equipment Design; Female; Femoral Artery; Humans; Limb Salvage; Lower Extremity; Male; Middle Aged; Paclitaxel; Popliteal Artery; Prospective Studies; Radiography; Recurrence; Rome; Severity of Illness Index; Stents; Thrombosis; Time Factors; Treatment Outcome; Vascular Access Devices	2012
Acute and long-term angiographic outcomes of side branch stenosis after randomized treatment of zotarolimus-, sirolimus-, and paclitaxel-eluting stent for coronary artery stenosis. Journal of Korean medical science, 2012, Volume: 27, Issue:12 Topics: Acute Disease; Aged; Blood Vessels; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Odds Ratio; Paclitaxel; Predictive Value of Tests; Sirolimus; Thrombosis; Treatment Outcome	2012
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. The New England journal of medicine, 2006, Sep-14, Volume: 355, Issue:11 Topics: Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Risk; Secondary Prevention; Single-Blind Method; Stents; Thrombosis	2006
Three-year follow-up of the first prospective randomized comparison between paclitaxel and sirolimus stents: the TAXi-LATE trial. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Aug-01, Volume: 70, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Prospective Studies; Prosthesis Design; Research Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2007
The paclitaxel-eluting Coroflex Please stent pilot study (PECOPS I) : the one-year clinical follow-up. Clinical research in cardiology : official journal of the German Cardiac Society, 2007, Volume: 96, Issue:11 Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Death; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Survival Rate; Thrombosis; Ticlopidine; Tubulin Modulators	2007
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA, 2008, Jan-30, Volume: 299, Issue:4 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis; Treatment Outcome	2008
[The incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease in the real world: a single center registry study]. Zhonghua xin xue guan bing za zhi, 2007, Volume: 35, Issue:12 Topics: Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Incidence; Male; Paclitaxel; Thrombosis	2007
Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. Journal of the American College of Cardiology, 2013, Dec-24, Volume: 62, Issue:25 Topics: Coronary Artery Bypass; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Percutaneous Coronary Intervention; Prospective Studies; Taxus; Thrombosis; Time Factors; Treatment Outcome	2013

Other Studies

140 other study(ies) available for paclitaxel and Blood Clot

Article	Year
Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells. European journal of pharmacology, 2021, Nov-05, Volume: 910 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; Citric Acid; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Humans; Mice; Myocytes, Smooth Muscle; Paclitaxel; Thrombosis; Vascular Remodeling	2021
Poor Below Knee Runoff Impacts Femoropopliteal Stent Failure and Fluoropolymer Antithrombotic Effect in Healthy Swine Model. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2023, Volume: 66, Issue:5 Topics: Animals; Constriction, Pathologic; Drug-Eluting Stents; Femoral Artery; Fibrinolytic Agents; Fluorocarbon Polymers; Neointima; Paclitaxel; Polymers; Stents; Swine; Thrombosis; Treatment Outcome	2023
VERY LATE STENT THROMBOSIS 2 YEARS AFTER IMPLANTATION OF A DRUG-ELUTING STENT (CASE REPORT). Georgian medical news, 2019, Issue:291 Topics: Adult; Drug-Eluting Stents; Humans; Male; Paclitaxel; Platelet Aggregation Inhibitors; Thrombosis; Time Factors; Treatment Outcome	2019
Removal of tumor thrombus from the azygos vein in an esophageal squamous cell carcinoma patient. Journal of cardiothoracic surgery, 2020, Mar-26, Volume: 15, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Azygos Vein; Chemotherapy, Adjuvant; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Thrombosis	2020
Cardiac Masses in a Patient With Pancreatic Adenocarcinoma and a History of Breast Carcinoma. JAMA oncology, 2020, 06-01, Volume: 6, Issue:6 Topics: Adenocarcinoma; Albumins; Anticoagulants; Breast Neoplasms; Deoxycytidine; Female; Gemcitabine; Heart Ventricles; Humans; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Thrombosis; Warfarin	2020
Clinical outcomes of polymer-free, paclitaxel-coated stents vs stent grafts in peripheral arterial disease patients with femoropopliteal artery lesions. Journal of vascular surgery, 2021, Volume: 73, Issue:6 Topics: Aged, 80 and over; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Cardiovascular Agents; Databases, Factual; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Japan; Limb Salvage; Male; Middle Aged; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Prosthesis Design; Reoperation; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Vascular Patency	2021
Carboplatin-paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosis. Minerva obstetrics and gynecology, 2022, Volume: 74, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cesarean Section; Female; Humans; Mastectomy; Neoplasm Recurrence, Local; Paclitaxel; Pregnancy; Thrombosis; Triple Negative Breast Neoplasms; Vena Cava, Superior	2022
Long-term Outcomes of Primary Percutaneous Coronary Intervention with Second-generation Drug-eluting Stents in ST-elevation Myocardial Infarction Patients Caused by Very Late Stent Thrombosis. Chinese medical journal, 2017, Apr-20, Volume: 130, Issue:8 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2017
A universal drug delivery catheter for the treatment of infrapopliteal arterial disease: Results from the multi-center first-in-human study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, 02-01, Volume: 91, Issue:2 Topics: Amputation, Surgical; Angioplasty, Balloon; Cardiovascular Agents; Catheterization, Peripheral; Constriction, Pathologic; Feasibility Studies; Female; Humans; Limb Salvage; Lower Extremity; Male; Paclitaxel; Peripheral Arterial Disease; Prospective Studies; Recurrence; Registries; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; United States; Vascular Access Devices; Vascular Patency	2018
Pro-Coagulant and Pro-Thrombotic Effects of Paclitaxel Mediated by Red Blood Cells. Thrombosis and haemostasis, 2018, Volume: 118, Issue:10 Topics: Adolescent; Animals; Antineoplastic Agents; Cell-Derived Microparticles; Drug-Related Side Effects and Adverse Reactions; Erythrocytes; Human Umbilical Vein Endothelial Cells; Humans; Male; Neoplasms; Paclitaxel; Phosphatidylserines; Phospholipid Transfer Proteins; Rats; Rats, Sprague-Dawley; Thrombin; Thrombosis; Young Adult	2018
Paclitaxel-coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real-world experience and longitudinal follow up. Nephrology (Carlton, Vic.), 2019, Volume: 24, Issue:12 Topics: Angioplasty, Balloon; Antineoplastic Agents, Phytogenic; Arteriovenous Shunt, Surgical; Coated Materials, Biocompatible; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Paclitaxel; Postoperative Complications; Renal Dialysis; Reoperation; Thrombosis; Treatment Outcome; Vascular Access Devices; Vascular Grafting; Vascular Patency	2019
The effect of short-term intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local thrombotic environment after angioplasty. Cardiovascular and interventional radiology, 2013, Volume: 36, Issue:4 Topics: Angioplasty, Balloon; Animals; Biopsy, Needle; Carotid Artery Injuries; Carotid Artery, Common; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hyperplasia; Immunohistochemistry; Infusions, Intra-Arterial; Male; Neointima; Paclitaxel; Random Allocation; Rats; Rats, Wistar; Risk Assessment; Thromboplastin; Thrombosis; Time Factors; Tissue Plasminogen Activator; Treatment Outcome	2013
Cilostazol protects vessels against hyperglycemic injury and accelerates healing after implantation of drug-eluting stent in a type 1 diabetes mellitus rat aorta stent model. Atherosclerosis, 2013, Volume: 228, Issue:2 Topics: Administration, Oral; Angioplasty, Balloon; Animals; Aorta; Aortic Diseases; Apoptosis; Blood Glucose; Cilostazol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug-Eluting Stents; Endothelial Cells; Intercellular Adhesion Molecule-1; Male; Neovascularization, Pathologic; Paclitaxel; Phosphodiesterase 3 Inhibitors; Prosthesis Design; Rats; Rats, Sprague-Dawley; Tetrazoles; Thrombosis; Time Factors; Vascular Cell Adhesion Molecule-1; von Willebrand Factor; Wound Healing	2013
Angioscopically apparent large thrombus and uncovered stent struts 6 months after late stent thrombosis of a paclitaxel-coated nitinol drug-eluting stent implanted in the superficial femoral artery. Cardiovascular intervention and therapeutics, 2014, Volume: 29, Issue:1 Topics: Aged; Alloys; Angiography; Angioscopy; Antineoplastic Agents, Phytogenic; Drug-Eluting Stents; Female; Femoral Artery; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Intermittent Claudication; Paclitaxel; Prosthesis Failure; Thrombosis; Time Factors	2014
Metformin impairs endothelialization after placement of newer generation drug eluting stents. Atherosclerosis, 2013, Volume: 229, Issue:2 Topics: Angioplasty, Balloon; Animals; Disease Models, Animal; Drug-Eluting Stents; Endothelium, Vascular; Everolimus; Hypoglycemic Agents; Iliac Artery; Immunosuppressive Agents; Male; Metformin; Paclitaxel; Rabbits; Sirolimus; Thrombosis; Tubulin Modulators	2013
Comparison of sirolimus-eluting, paclitaxel-eluting, and bare-metal stents in a patient with angina pectoris: histopathological autopsy findings of the third month. Cardiovascular intervention and therapeutics, 2014, Volume: 29, Issue:4 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Autopsy; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Fatal Outcome; Humans; Male; Paclitaxel; Postoperative Complications; Sirolimus; Thrombosis; Treatment Outcome	2014
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. European heart journal, 2014, Volume: 35, Issue:12 Topics: Animals; Cell Proliferation; Cells, Cultured; Chemotaxis; Drug-Eluting Stents; Endothelium, Vascular; GTP Phosphohydrolases; Hydrazones; Immunosuppressive Agents; Leukocytes, Mononuclear; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Neointima; NF-kappaB-Inducing Kinase; Nitric Oxide; Paclitaxel; Phosphoinositide-3 Kinase Inhibitors; Plasminogen Activator Inhibitor 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Sirolimus; Sulfonamides; Thrombosis; Tumor Necrosis Factor-alpha	2014
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents. The American journal of cardiology, 2014, Jun-15, Volume: 113, Issue:12 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Retrospective Studies; Severity of Illness Index; Sirolimus; Survival Analysis; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment	2014
Stent thrombosis is not increased following percutaneous coronary intervention in patients with non-insulin dependent diabetes mellitus taking metformin. Atherosclerosis, 2014, Volume: 235, Issue:2 Topics: Aged; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Humans; Male; Metformin; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Stents; Thrombosis	2014
Comparison of long-term clinical outcomes between sirolimus- and paclitaxel-eluting stents in real-world clinical practice. Heart and vessels, 2015, Volume: 30, Issue:6 Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Paclitaxel; Percutaneous Coronary Intervention; Prosthesis Design; Risk Factors; Sirolimus; Thrombosis; Treatment Outcome	2015
"Very" very late stent thrombosis: acute myocardial infarction from drug-eluting stent thrombosis more than 5 years after implantation. The Journal of invasive cardiology, 2014, Volume: 26, Issue:9 Topics: Adult; Aged; Aspirin; Dose-Response Relationship, Drug; Drug-Eluting Stents; Female; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Sirolimus; Thrombosis; Time Factors	2014
Insights into very late stent thrombosis from the wisdom of pathology. The Journal of invasive cardiology, 2014, Volume: 26, Issue:9 Topics: Drug-Eluting Stents; Female; Humans; Male; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis	2014
1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis. JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:8 Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Drug-Eluting Stents; Endovascular Procedures; Female; Femoral Artery; Humans; Japan; Kaplan-Meier Estimate; Linear Models; Male; Multivariate Analysis; Odds Ratio; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Radiography; Recurrence; Risk Factors; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency	2015
Vascular restoration: Is there a window of opportunity? Medical hypotheses, 2015, Volume: 85, Issue:6 Topics: Angioplasty, Balloon, Coronary; Biocompatible Materials; Cell Proliferation; Coronary Angiography; Coronary Restenosis; Disease Progression; Drug-Eluting Stents; Humans; Metals; Muscle, Smooth, Vascular; Paclitaxel; Polymers; Thrombosis; Treatment Outcome	2015
Two-year clinical outcome in patients with small coronary artery disease treated with everolimus- versus paclitaxel-eluting stenting. Journal of cardiology, 2016, Volume: 68, Issue:3 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Japan; Male; Paclitaxel; Percutaneous Coronary Intervention; Registries; Retreatment; Thrombosis	2016
Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry). Medical science monitor : international medical journal of experimental and clinical research, 2015, Oct-27, Volume: 21 Topics: Aged; Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Poland; Proportional Hazards Models; Registries; Retrospective Studies; Sirolimus; Stents; Thrombosis; Treatment Outcome	2015
Is there a preferable DES in diabetic patients? A critical appraisal of the evidence. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Dec-01, Volume: 72, Issue:7 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin; Meta-Analysis as Topic; Metals; Paclitaxel; Patient Selection; Prosthesis Design; Randomized Controlled Trials as Topic; Registries; Risk Assessment; Sirolimus; Thrombosis; Treatment Outcome	2008
[Benefit-risk ratio of coronary drug-eluting stents: 2nd part: evaluation in the diabetic population]. Revue medicale de Liege, 2008, Volume: 63, Issue:11 Topics: Coronary Artery Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Incidence; Paclitaxel; Postoperative Complications; Risk Assessment; Sirolimus; Thrombosis	2008
Cost-effectiveness of drug-eluting stents including the economic impact of late stent thrombosis. The American journal of cardiology, 2009, Feb-01, Volume: 103, Issue:3 Topics: Aged; Clopidogrel; Cost-Benefit Analysis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Ticlopidine	2009
2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). Journal of the American College of Cardiology, 2009, Feb-24, Volume: 53, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis	2009
Incidence of stent thrombosis in patients with drug eluting stents and short-term dual antiplatelet therapy. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 4, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Artery Disease; Databases as Topic; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2009
Images in intervention. Optical coherence tomography findings in very late (4 years) paclitaxel-eluting stent thrombosis. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Suction; Thrombectomy; Thrombosis; Time Factors; Tomography, Optical Coherence; Ultrasonography, Interventional	2008
The process of bringing new drug-eluting stents to market will they see the light of day? JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Humans; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2008
The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:6 Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2009
Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire international, 2009, Volume: 18, Issue:100 Topics: Angina, Unstable; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome	2009
Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet.... Clinical pharmacology and therapeutics, 2009, Volume: 86, Issue:2 Topics: Alloys; Cardiovascular Agents; Clinical Trials as Topic; Coronary Restenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Incidence; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Thrombosis; Time Factors	2009
Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:8 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2009
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:8 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; United States	2009
Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies. Journal of cardiology, 2009, Volume: 54, Issue:2 Topics: Acute Coronary Syndrome; Angina, Unstable; Clinical Trials as Topic; Drug-Eluting Stents; Europe; Humans; Incidence; Japan; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Sirolimus; Thrombosis; Ticlopidine; United States	2009
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromosomes, Human, Pair 9; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2009
Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Registries; Sirolimus; Thrombosis; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima	2010
High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries. Circulation. Cardiovascular interventions, 2008, Volume: 1, Issue:1 Topics: Angioscopy; Animals; Blood Vessel Prosthesis Implantation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Incidence; Male; Paclitaxel; Swine; Thrombosis; Vasodilation	2008
Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation. Circulation. Cardiovascular interventions, 2008, Volume: 1, Issue:2 Topics: Aged; Blood Vessel Prosthesis Implantation; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Survival Analysis; Thrombosis; Time Factors; Treatment Outcome	2008
Long-term paclitaxel-eluting stent outcomes in elderly patients. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Paclitaxel; Patient Selection; Proportional Hazards Models; Randomized Controlled Trials as Topic; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome	2009
Off-label use and the spectre of drug-eluting stent thrombosis. Circulation. Cardiovascular interventions, 2009, Volume: 2, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Myocardial Infarction; Off-Label Use; Paclitaxel; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome	2009
3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Mar-01, Volume: 75, Issue:4 Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; England; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Thrombosis; Time Factors; Treatment Outcome	2010
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Double-Blind Method; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Metals; Middle Aged; Odds Ratio; Paclitaxel; Predictive Value of Tests; Prospective Studies; Prosthesis Design; Risk Assessment; Risk Factors; ROC Curve; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency	2009
Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Brazil; Calcinosis; Cardiovascular Agents; Coronary Restenosis; Disease-Free Survival; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Diseases; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
Letter by Virmani et al regarding article, "Drug-eluting stents in animals and patients: where do we stand today?". Circulation, 2010, Mar-23, Volume: 121, Issue:11 Topics: Animals; Disease Models, Animal; Drug-Eluting Stents; Humans; Paclitaxel; Risk Factors; Sirolimus; Swine; Thrombosis	2010
Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
Bifurcation stenting: a commitment to always kiss. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Mar-01, Volume: 75, Issue:4 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Artery Disease; Disease-Free Survival; Drug-Eluting Stents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Thrombosis; Time Factors; Treatment Outcome	2010
Everolimus-eluting versus paclitaxel-eluting stents. Lancet (London, England), 2010, Apr-03, Volume: 375, Issue:9721 Topics: Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Thrombosis	2010
Everolimus-eluting versus paclitaxel-eluting stents. Lancet (London, England), 2010, Apr-03, Volume: 375, Issue:9721 Topics: Drug-Eluting Stents; Equipment Design; Everolimus; Humans; Hypersensitivity; Immunosuppressive Agents; Nickel; Paclitaxel; Sirolimus; Thrombosis	2010
Sirolimus- versus paclitaxel-eluting stents for the treatment of cardiac allograft vasculopathy. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Heart Transplantation; Humans; Italy; Los Angeles; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Retrospective Studies; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Transplantation, Homologous; Treatment Outcome	2010
Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report. Journal of cardiovascular medicine (Hagerstown, Md.), 2011, Volume: 12, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Drug Administration Schedule; Drug-Eluting Stents; Electrocardiography; Female; Hemorrhage; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Thrombosis; Time Factors	2011
Second-generation drug-eluting coronary stents. The New England journal of medicine, 2010, May-06, Volume: 362, Issue:18 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Cost-Benefit Analysis; Diabetes Complications; Drug-Eluting Stents; Everolimus; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Thrombosis; Treatment Outcome	2010
Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Netherlands; Paclitaxel; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2009
Incomplete stent apposition: should we appose or oppose? JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Humans; Metals; Paclitaxel; Prosthesis Design; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2010
Sirolimus versus paclitaxel coronary stents in clinical practice. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jan-01, Volume: 77, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Switzerland; Thrombosis; Time Factors; Treatment Outcome	2011
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Denmark; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2010, Volume: 5, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Europe; Female; Follow-Up Studies; Hospital Mortality; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome	2010
Clinical and angiographic outcomes of drug-eluting stents in patients with large vessel and single coronary artery lesion. Clinical cardiology, 2010, Volume: 33, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Hospital Mortality; Hospitals, University; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Republic of Korea; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Female; Germany; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Prospective Studies; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome	2010
Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Jul-01, Volume: 76, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome	2010
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; China; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; ROC Curve; Thrombosis; Time Factors; Treatment Outcome	2010
Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions: results from the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) program. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Bypass; Coronary Restenosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Saphenous Vein; Thrombosis; Time Factors; Treatment Outcome; United States	2010
Complete resolution of very late stent thrombosis with systemic thrombolysis. Journal of cardiovascular medicine (Hagerstown, Md.), 2011, Volume: 12, Issue:10 Topics: Adult; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Drug-Eluting Stents; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Thrombolytic Therapy; Thrombosis; Time Factors; Treatment Outcome	2011
Usage patterns and 1-year outcomes with the TAXUS Liberté stent: results of the TAXUS OLYMPIA registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jun-01, Volume: 77, Issue:7 Topics: Africa, Northern; Aged; Angioplasty, Balloon, Coronary; Asia; Cardiovascular Agents; Diabetes Mellitus; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Practice Patterns, Physicians'; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Regression Analysis; Risk Assessment; Risk Factors; South America; Thrombosis; Time Factors; Treatment Outcome	2011
The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEA JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2010
Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Japan; Male; Metals; Middle Aged; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima	2011
The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Dec-01, Volume: 76, Issue:7 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Humans; Hypersensitivity; Myocardial Infarction; Paclitaxel; Prosthesis Design; Sirolimus; Syndrome; Thrombosis; Treatment Outcome	2010
Impact of cytochrome P450 2C192 polymorphism on intra-stent thrombus after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:1* Topics: Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Cardiovascular Agents; Chi-Square Distribution; Cineangiography; Clopidogrel; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Japan; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2011
High glycemic stenting menu. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Dec-01, Volume: 76, Issue:7 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Stenosis; Diabetes Complications; Drug-Eluting Stents; Humans; Hypoglycemic Agents; Insulin; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2010
Neointimal coverage over coronary stent struts crossing the side branch Ostia. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Vessels; Drug-Eluting Stents; Humans; Metals; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Tunica Intima	2011
Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Jan-01, Volume: 77, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Stenosis; Diabetes Mellitus; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 6, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Two-year outcome of Turkish patients treated with Zotarolimus versus Paclitaxel eluting stents in an unselected population with coronary artery disease in the real world: a prospective non-randomized registry in southern Turkey. International journal of medical sciences, 2011, Jan-08, Volume: 8, Issue:1 Topics: Aged; Cardiovascular Agents; Coronary Artery Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Patient Selection; Postoperative Complications; Prospective Studies; Random Allocation; Registries; Retrospective Studies; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Turkey	2011
Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Metals; Myocardial Infarction; Paclitaxel; Prosthesis Design; Recurrence; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metals; Myocardial Infarction; North Carolina; Paclitaxel; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Recurrence; Registries; Risk Assessment; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2011
If I've heard it once, I've heard it (not yet) a hundred times. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2011, Mar-01, Volume: 77, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents. The American journal of cardiology, 2011, Jun-15, Volume: 107, Issue:12 Topics: Aged; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis; Treatment Outcome	2011
Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions. Clinical cardiology, 2011, Volume: 34, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2011
Origin of restenosis after drug-eluting stent implantation in hyperglycemia is inflammatory cells and thrombus. Journal of atherosclerosis and thrombosis, 2011, Volume: 18, Issue:7 Topics: Animals; Anti-Inflammatory Agents; Aorta; Body Weight; Coronary Restenosis; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug-Eluting Stents; Fibrin; Humans; Hyaluronic Acid; Hyperglycemia; Inflammation; Male; Paclitaxel; Rats; Rats, Sprague-Dawley; Sirolimus; Thrombosis	2011
Risk of in-stent thrombus formation at one year after drug-eluting stent implantation. Thrombosis research, 2011, Volume: 128, Issue:5 Topics: Aged; Angioscopy; Color; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Neointima; Paclitaxel; Regression Analysis; Risk; Risk Factors; Thrombosis	2011
Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 7, Issue:3 Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Thrombosis; Treatment Outcome	2011
Interventional cardiology: Antithrombotic drug and stent choices in primary PCI. Nature reviews. Cardiology, 2011, Aug-09, Volume: 8, Issue:9 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Fibrinolytic Agents; Hirudins; Humans; Myocardial Infarction; Paclitaxel; Peptide Fragments; Prosthesis Design; Randomized Controlled Trials as Topic; Recombinant Proteins; Thrombosis; Time Factors; Treatment Outcome	2011
Comparison of efficacy between paclitaxel-eluting stents with different polymers in terms of major adverse cardiac events and stent thrombosis up to 12 months of clinical follow-up. International journal of cardiology, 2011, Nov-03, Volume: 152, Issue:3 Topics: Aged; Cardiovascular Diseases; Cohort Studies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymers; Retrospective Studies; Thrombosis; Treatment Outcome	2011
Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Volume: 7, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Contraindications; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Prospective Studies; Registries; Sirolimus; Stents; Thrombosis; Titanium; Treatment Outcome	2012
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Oct-30, Volume: 7, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Patient Selection; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Treatment Outcome	2011
Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2012, Volume: 80, Issue:3 Topics: Absorbable Implants; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Drug Carriers; Drug-Eluting Stents; Ethylene Oxide; Excipients; Kinetics; Paclitaxel; Polyethylenes; Polymers; Thrombosis	2012
Drug coated balloons in acute coronary syndromes--opportunities and limitations. Current vascular pharmacology, 2012, Volume: 10, Issue:4 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Arrhythmias, Cardiac; Combined Modality Therapy; Coronary Restenosis; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Surface Properties; Thrombosis	2012
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Texas Heart Institute journal, 2012, Volume: 39, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chi-Square Distribution; Coronary Artery Disease; Drug-Eluting Stents; Female; Guideline Adherence; Hospital Mortality; Humans; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Practice Guidelines as Topic; Product Labeling; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:2 Topics: Aged; Aged, 80 and over; Atherectomy, Coronary; Cardiovascular Agents; Comorbidity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Incidence; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Sirolimus; Stroke; Thrombosis; Time Factors; Treatment Outcome; Vascular Calcification	2013
Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:5 Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Diabetic Angiopathies; Disease-Free Survival; District of Columbia; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2013
Altered microtubule equilibrium and impaired thrombus stability in mice lacking RanBP10. Blood, 2012, Oct-25, Volume: 120, Issue:17 Topics: Animals; Arteries; Blood Platelets; Chlorides; Collagen; Cytoplasmic Granules; Ferric Compounds; Gene Expression; Guanine Nucleotide Exchange Factors; Hemorheology; Mice; Mice, Knockout; Microtubule-Associated Proteins; Microtubules; Paclitaxel; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Polymerization; Protein Isoforms; Signal Transduction; Thrombosis; Tubulin; von Willebrand Factor	2012
Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stents. Journal of interventional cardiology, 2013, Volume: 26, Issue:1 Topics: Cardiotonic Agents; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Racial Groups; Randomized Controlled Trials as Topic; Thrombosis	2013
[Comparing moderately late results of the application of stents coated with a medicinal antiproliferative agent for the treatment of patients with various forms of coronary heart disease: their efficacy and safety]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:6 Topics: Adult; Cell Proliferation; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Endovascular Procedures; Follow-Up Studies; Humans; Paclitaxel; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. European heart journal. Cardiovascular Imaging, 2013, Volume: 14, Issue:9 Topics: Aged; Angina Pectoris; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Prolapse; Prosthesis Failure; Retrospective Studies; Sensitivity and Specificity; Sirolimus; Thrombosis; Tomography, Optical Coherence	2013
Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry. Journal of interventional cardiology, 2013, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Registries; Sirolimus; Thrombosis; Treatment Outcome	2013
Risk of noncardiac surgery in the months following placement of a drug-eluting coronary stent. Journal of the American College of Cardiology, 2004, Feb-18, Volume: 43, Issue:4 Topics: Coronary Stenosis; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Surgical Procedures, Operative; Thrombosis; Time Factors	2004
Paclitaxel-eluting coronary stents. The New England journal of medicine, 2004, May-13, Volume: 350, Issue:20 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Stents; Thrombosis; Ticlopidine	2004
Problems with drug-eluting coronary stents--the FDA perspective. The New England journal of medicine, 2004, Oct-14, Volume: 351, Issue:16 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Device Approval; Drug Delivery Systems; Equipment Failure; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; United States; United States Food and Drug Administration	2004
Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation, 2005, Apr-05, Volume: 111, Issue:13 Topics: Animals; Arteries; Blood Coagulation; Computer Simulation; Diffusion; Humans; Male; Paclitaxel; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Stents; Thrombosis; Tissue Distribution	2005
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA, 2005, May-04, Volume: 293, Issue:17 Topics: Angioplasty, Balloon, Coronary; Drug Delivery Systems; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Risk; Sirolimus; Stents; Thrombosis	2005
[Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation]. Annales francaises d'anesthesie et de reanimation, 2005, Volume: 24, Issue:10 Topics: Acute Disease; Antineoplastic Agents, Phytogenic; Cardiomyopathy, Dilated; Heart Transplantation; Heart-Assist Devices; Humans; Leg; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Sirolimus; Stents; Thrombosis; Vascular Surgical Procedures	2005
Pharmacists' role in preventing stent thrombosis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Nov-01, Volume: 62, Issue:21 Topics: Antineoplastic Agents; Coronary Restenosis; Humans; Paclitaxel; Patient Compliance; Pharmacists; Product Surveillance, Postmarketing; Professional Role; Stents; Thrombosis	2005
Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. Journal of the American College of Cardiology, 2006, Jan-03, Volume: 47, Issue:1 Topics: Aged; Coronary Restenosis; Coronary Vessels; Female; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Thrombosis	2006
Drug-eluting stent thrombosis: a pooled analysis. Journal of the American College of Cardiology, 2006, Jan-03, Volume: 47, Issue:1 Topics: Coronary Vessels; Humans; Paclitaxel; Sirolimus; Stents; Thrombosis	2006
Thrombosis after implantation of drug-eluting stents. JAMA, 2006, Jan-04, Volume: 295, Issue:1 Topics: Angioplasty, Balloon, Coronary; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Thrombosis	2006
Procedural success and 30 day outcomes between CYPHER and TAXUS stent implantation for the treatment of bifurcation lesions--a single-center experience. The Journal of invasive cardiology, 2006, Volume: 18, Issue:2 Topics: Acute Disease; Aged; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Registries; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2006
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation, 2006, Feb-28, Volume: 113, Issue:8 Topics: Aged; Angiography; Case-Control Studies; Clopidogrel; Drug Delivery Systems; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Renal Insufficiency; Sirolimus; Stents; Thrombosis; Ticlopidine; Treatment Outcome	2006
Peripheral arterial thrombosis induced by chemotherapy in ovarian carcinoma coexisted with endometrial carcinoma. Archives of gynecology and obstetrics, 2007, Volume: 275, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Endometrial Neoplasms; Fatal Outcome; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Vascular Diseases; Postmenopause; Thrombocytopenia; Thrombosis	2007
Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circulation research, 2006, Jul-21, Volume: 99, Issue:2 Topics: Aorta; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Gene Expression Regulation; Humans; JNK Mitogen-Activated Protein Kinases; Paclitaxel; Stents; Thrombin; Thromboplastin; Thrombosis	2006
Letter by Tsai et al regarding article, "correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and Paclitaxel-eluting stents". Circulation, 2006, Aug-22, Volume: 114, Issue:8 Topics: Angiography; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents; Thrombosis; Treatment Outcome	2006
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation, 2006, Nov-14, Volume: 114, Issue:20 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Drug Delivery Systems; Equipment Design; Humans; Incidence; Metals; Myocardial Infarction; Paclitaxel; Registries; Retreatment; Risk Assessment; Sirolimus; Stents; Thrombosis; Treatment Outcome	2006
Late stent thrombosis in drug-eluting stents: return of the 'VB syndrome'. Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:12 Topics: Humans; Incidence; Meta-Analysis as Topic; Paclitaxel; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2006
Drug-eluting stent thrombosis: it's never too late. Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:12 Topics: Humans; Incidence; Meta-Analysis as Topic; Paclitaxel; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2006
Drug-eluting stents in primary PCI. The New England journal of medicine, 2006, Dec-07, Volume: 355, Issue:23 Topics: Angioplasty, Balloon, Coronary; Confounding Factors, Epidemiologic; Coronary Angiography; Coronary Restenosis; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis	2006
[Coronary stents and anaesthesia: it is time to have national data]. Annales francaises d'anesthesie et de reanimation, 2007, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Anesthesia, General; Coronary Restenosis; Coronary Stenosis; Drug Implants; Female; France; Hematoma; Humans; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Registries; Sirolimus; Stents; Surgical Procedures, Operative; Thrombophilia; Thrombosis	2007
Does clopidogrel each day keep stent thrombosis away? JAMA, 2007, Jan-10, Volume: 297, Issue:2 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Thrombosis; Ticlopidine	2007
Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique". Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jun-01, Volume: 69, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Databases as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Pilot Projects; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2007
Do the benefits outweigh the risks with drug-eluting stents? Scandinavian cardiovascular journal : SCJ, 2007, Volume: 41, Issue:1 Topics: Coronary Restenosis; Everolimus; Humans; Paclitaxel; Patient Selection; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Assessment; Sirolimus; Stents; Thrombosis	2007
Late coronary thrombosis in paclitaxel-eluting stents. Case reports. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:4 Topics: Adult; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Disease; Delayed-Action Preparations; Drug Administration Schedule; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Thrombosis; Time Factors	2007
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA, 2007, May-09, Volume: 297, Issue:18 Topics: Aged; Angioplasty, Balloon, Coronary; Consumer Product Safety; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk; Sirolimus; Stents; Survival Analysis; Thrombosis; Treatment Outcome; United States	2007
Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Aug-01, Volume: 70, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Coronary Angiography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Research Design; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Treatment Outcome	2007
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. Journal of the American College of Cardiology, 2007, Jun-19, Volume: 49, Issue:24 Topics: Adult; Antineoplastic Agents, Phytogenic; Blood Platelets; Clopidogrel; Comorbidity; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Myocardial Ischemia; Paclitaxel; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Sirolimus; Stents; Thrombosis; Ticlopidine	2007
What kind of stent for you today and how would you like it prepared? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Aug-01, Volume: 70, Issue:2 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Humans; Myocardial Ischemia; Paclitaxel; Patient Selection; Prosthesis Design; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Treatment Outcome	2007
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation, 2007, Aug-14, Volume: 116, Issue:7 Topics: Aged; Aspirin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus; Stents; Thrombosis; Treatment Outcome	2007
Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation, 2007, Aug-14, Volume: 116, Issue:7 Topics: Algorithms; Aspirin; Clopidogrel; Drug Therapy, Combination; Humans; Incidence; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Sirolimus; Stents; Survivors; Thrombosis; Ticlopidine	2007
Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model. Cardiovascular research, 2007, Nov-01, Volume: 76, Issue:2 Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Vessels; Drug-Eluting Stents; Inflammation; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Paclitaxel; Swine; Thrombosis; Tunica Intima	2007
The lack of endothelization after drug-eluting stent implantation as a cause of fatal late stent thrombosis. Journal of thrombosis and thrombolysis, 2008, Volume: 26, Issue:2 Topics: Angioplasty, Balloon, Coronary; Autopsy; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Drug-Eluting Stents; Endothelial Cells; Fatal Outcome; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Thrombosis; Ticlopidine; Treatment Outcome	2008
Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents? Medical hypotheses, 2008, Volume: 70, Issue:3 Topics: Cell Division; Cell Movement; Coronary Restenosis; Drug-Eluting Stents; Endothelium, Vascular; Erythroid Precursor Cells; Humans; Paclitaxel; Sirolimus; Stents; Thrombosis; Treatment Failure	2008
Drug-eluting stents and late stent thrombosis. Lancet (London, England), 2007, Sep-15, Volume: 370, Issue:9591 Topics: Anti-Bacterial Agents; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Thrombosis	2007
Late coronary stent thrombosis complicating urologic surgery. European urology, 2008, Volume: 54, Issue:1 Topics: Aged; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Fatal Outcome; Humans; Immunosuppressive Agents; Lymph Node Excision; Male; Paclitaxel; Platelet Aggregation Inhibitors; Prostatic Neoplasms; Thrombosis; Ticlopidine; Withholding Treatment	2008
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. The American journal of cardiology, 2008, Jan-01, Volume: 101, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Multivariate Analysis; Myocardial Infarction; Myocardium; Necrosis; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Retreatment; Saphenous Vein; Sirolimus; Stents; Thrombosis	2008
Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. International immunopharmacology, 2008, Volume: 8, Issue:2 Topics: Cells, Cultured; Humans; Muscle, Smooth, Vascular; Paclitaxel; Sirolimus; Thromboplastin; Thrombosis; Up-Regulation	2008
Effectiveness of drug-eluting stents in real-world patients. JAMA, 2008, Jan-30, Volume: 299, Issue:4 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Sirolimus; Thrombosis	2008
Stenting unprotected left main: the outcome is not always favorable. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Mar-01, Volume: 71, Issue:4 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Humans; Myocardial Infarction; Paclitaxel; Patient Selection; Risk Assessment; Severity of Illness Index; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2008
Connective tissue changes in a mouse model of vein graft disease. The Journal of cardiovascular surgery, 2008, Volume: 49, Issue:2 Topics: Animals; Apoptosis; Carotid Arteries; Collagen; Connective Tissue; Glycosaminoglycans; Graft Occlusion, Vascular; Hyperplasia; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Paclitaxel; Thrombosis; Tunica Intima; Vena Cava, Inferior	2008
Thrombosis with paclitaxel. Lancet (London, England), 1994, Mar-19, Volume: 343, Issue:8899 Topics: Breast Neoplasms; Female; Humans; Ovarian Neoplasms; Paclitaxel; Thrombosis	1994